Diagnostica Stago
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Diagnostica Stago sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Diagnostica Stago: 5 sponsored US clinical trials, none currently recruiting.
Diagnostica Stago sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is Anticoagulation With Apixaban, with 1 trials.
Upper-quartile sponsor footprint
Diagnostica Stago sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
ThRombosis ExclUsion STudy
NCT03477968
Apixaban Validation Study - Additional Study on Fresh Samples
NCT03073265
Validation of Rivaroxaban Assay for US Registration
NCT02333929
Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis
NCT02078154
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
NCT01221805
Therapeutic Areas
How the Diagnostica Stago archive is shaped
5 indexed studies, none listed as recruiting (0% open); 3 completed (60%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Anticoagulation With Apixaban (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Diagnostica Stago: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Diagnostica Stago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Diagnostica Stago page
5 registered trials is a research-attention snapshot, not an endorsement of Diagnostica Stago or any single study.
- None of Diagnostica Stago's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Anticoagulation With Apixaban is the condition Diagnostica Stago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anticoagulation With Apixaban trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Diagnostica Stago pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.